Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Ski2670
2. Tu2670
1. 1454272-94-6
2. 4-[[(1r)-2-[1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-2,4-dioxo-1'-[[5-(trifluoromethyl)furan-2-yl]methyl]spiro[7h-furo[3,4-d]pyrimidine-5,4'-piperidine]-3-yl]-1-phenylethyl]amino]butanoic Acid
3. Merigolix [inn]
4. Rs62jyv9lx
5. Nce403
6. Schembl16783282
7. Gtpl12394
8. Ski2670
9. Ljpsgsmpgvithk-mhzltwqesa-n
10. Glxc-26904
11. Tu2670
12. Tu-2670
13. Example 2-13 [us9481684b2]
14. Formula 1 [us20220002312a1]
15. Hy-152856
16. Cs-0641182
17. 4-[[(1r)-2-[1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1,2,4,7-tetrahydro-2,4-dioxo-1'-[[5-(trifluoromethyl)-2-furanyl]methyl]spiro[furo[3,4-d]pyrimidine-5(3h),4'-piperidin]-3-yl]-1-phenylethyl]amino]butanoic Acid
18. 4-{[(1r)-2-(1-{[2-fluoro-6- (trifluoromethyl)phenyl]methyl}-2,4-dioxo-1'-{[5- (trifluoromethyl)furan-2-yl]methyl}-1,2,4,7-tetrahydro- 3h-spiro[furo[3,4-d]pyrimidine-5,4'-piperidin]-3-yl)-1- Phenylethyl]amino}butanoic Acid
19. 4-{[(1r)-2-(1-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-2,4-dioxo-1'-{[5-(trifluoromethyl)furan-2-yl]methyl}-1,2,4,7-tetrahydro3h-spiro[furo[3,4-d]pyrimidine-5,4'-piperidin]-3-yl)-1-phenylethyl]amino}butanoic Acid
20. Butanoic Acid, 4-[[(1r)-2-[1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-1,2,4,7-tetrahydro-2,4-dioxo-1'-[[5-(trifluoromethyl)-2-furanyl]methyl]spiro[furo[3,4-d]pyrimidine-5(3h),4'-piperidin]-3-yl]-1-phenylethyl]amino]-
| Molecular Weight | 752.7 g/mol |
|---|---|
| Molecular Formula | C36H35F7N4O6 |
| XLogP3 | 1.7 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 15 |
| Rotatable Bond Count | 12 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 116 |
| Heavy Atom Count | 53 |
| Formal Charge | 0 |
| Complexity | 1360 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
95
PharmaCompass offers a list of Merigolix API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Merigolix manufacturer or Merigolix supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Merigolix manufacturer or Merigolix supplier.
PharmaCompass also assists you with knowing the Merigolix API Price utilized in the formulation of products. Merigolix API Price is not always fixed or binding as the Merigolix Price is obtained through a variety of data sources. The Merigolix Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Merigolix manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Merigolix, including repackagers and relabelers. The FDA regulates Merigolix manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Merigolix API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Merigolix supplier is an individual or a company that provides Merigolix active pharmaceutical ingredient (API) or Merigolix finished formulations upon request. The Merigolix suppliers may include Merigolix API manufacturers, exporters, distributors and traders.
Merigolix Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Merigolix GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Merigolix GMP manufacturer or Merigolix GMP API supplier for your needs.
A Merigolix CoA (Certificate of Analysis) is a formal document that attests to Merigolix's compliance with Merigolix specifications and serves as a tool for batch-level quality control.
Merigolix CoA mostly includes findings from lab analyses of a specific batch. For each Merigolix CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Merigolix may be tested according to a variety of international standards, such as European Pharmacopoeia (Merigolix EP), Merigolix JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Merigolix USP).
